We’ve moved! PSR Orphan Experts is now Ergomed. To stay updated on future news, please follow us on the Ergomed LinkedIn page at https://www.linkedin.com/company/ergomed-clinical-research/ PSR Group, now Ergomed, is a Contract Research Organisation providing a wide array of services to biotech and pharma companies in the rare disease niche. It is our mission to make a significant innovative contribution to the availability of new treatments for rare disease patients. PSR Orphan Experts has successfully prepared EMA and FDA Orphan Drug Designation applications and supported regulatory interactions, as well as established links with physician networks, key opinion leaders, government bodies and patient groups. PSR has a vast experience of conducting complex clinical trials in a variety of rare indications. Besides outsourced project solutions, PSR provides insourced staffing solutions (orphan drug teams), temporary and permanent staffing, interim management solutions, as well as training / coaching career programs. Drawing on more than 20 years of expertise in drug development, Ergomed provides specialist services to the pharmaceutical industry and develops drugs both wholly-owned and through partnerships. Ergomed’s fast-growing, profitable service offering spans all phases of clinical development, as well as post-approval pharmacovigilance and medical information. More information: https://www.ergomedplc.com/